BMS-243117
BMS-243117 is a potent, and selective benzothiazole based p56Lck inhibitor with an IC50 of 4 nM. BMS-243117 inhibits anti-CD3/anti-CD28 induced PBL (human peripheral blood T-cells) proliferation with an IC50 of 1.1 μM. BMS-243117 binds in an extended conformation to the ATP-binding site of Lck.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 225521-80-2
- Formel: C20H21ClN4O2S
- Molecular Weight:416.92
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Biologische Aktivität
|
Lck 4 nM (IC50) |
Fyn 32 nM (IC50) |
Blk 84 nM (IC50) |
Src 158 nM (IC50) |
Hck 960 nM (IC50) |
Lyn 330 nM (IC50) |
Fgr 60 nM (IC50) |
Chemical Information
-
CAS. Nr. 225521-80-2
-
Molecular Weight 416.92
-
Formel C20H21ClN4O2S
-
SMILES
O=C(C1=CC=C2N=C(NC(NC(C)(C)C)=O)SC2=C1)NC3=C(C)C=CC=C3Cl
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
BMS-243117 Related Classifications
HY-120622 Related Classifications
Powered by Bioz